PATENT CLAIM ANALYSIS

Application Number: 15744712
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "016800"]

Abstract:
Provided are fusion polypeptides comprising fragments from a first and a second FGF family member, nucleic acids encoding the fusion polypeptides, vectors and host cells containing the same, and methods of making and using such compositions in the treatment of FGF-related diseases, disorders, and conditions.

Claim (Index 6):
The fusion polypeptide of any of the preceding claims, wherein the fusion polypeptide has the ability to promote growth of BaF3 cells expressing said FGF receptor in vitro when applied at a concentration of less than about 1 \u03bcg/ml, 100 ng/ml, 90 ng/ml, 80 ng/ml, 70 ng/ml, 60 ng/ml, 50 ng/ml, 40 ng/ml, 30 ng/ml, 29 ng/ml, 28 ng/ml, 27 ng/ml, 26 ng/ml, 25 ng/ml, 24 ng/ml, 23 ng/ml, 22 ng/ml, 21 ng/ml, 20 ng/ml, 19 ng/ml, 18 ng/ml, 17 ng/ml, 16 ng/ml, 15 ng/ml, 14 ng/ml, 13 ng/ml, 12 ng/ml, 11 ng/ml, 10 ng/ml, 9 ng/ml, 8 ng/ml, 7 ng/ml, 6 ng/ml, 5 ng/ml, 4 ng/ml, 3 ng/ml, 2 ng/ml, 1.5 ng/ml, 1 ng/ml, 0.9 ng/ml, 0.8 ng/ml, 0.7 ng/ml, 0.6 ng/ml, 0.5 ng/ml, 0.4 ng/ml, 0.3 ng/ml, 0.2 ng/ml, or 0.1 ng/ml.

Metadata:
- Claim Count in Document: 112.0
- Percentile: 86.0
- Lexical Diversity: 1.37838
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15107101', '14380277', '13515429', '15660116', '10251947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7758971287106471
- 35 USC 102 Novelty (BERT): 0.5474340650430253
- Combined Prediction Score: 0.753050822343885
- Mean Citation Score: 314.01251
- Max Citation Score: 411.7714
- Similarity Product: 285.2806440226078

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test